Detalles de la búsqueda
1.
SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency.
Cell
; 187(3): 596-608.e17, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38194966
2.
The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic.
Cell
; 185(3): 447-456.e11, 2022 02 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35026151
3.
COVID-19 immune signatures reveal stable antiviral T cell function despite declining humoral responses.
Immunity
; 54(2): 340-354.e6, 2021 02 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33567252
4.
Status of HIV and comorbidities in refugees with HIV from Ukraine.
HIV Med
; 25(4): 479-483, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38043508
5.
Limited Weight Impact After Switching From Boosted Protease Inhibitors to Dolutegravir in Persons With Human Immunodeficiency Virus With High Cardiovascular Risk: A Post Hoc Analysis of the 96-Week NEAT-022 Randomized Trial.
Clin Infect Dis
; 76(5): 861-870, 2023 03 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36259527
6.
Incidence of Hypertension and Blood Pressure Changes in Persons With Human Immunodeficiency Virus at High Risk for Cardiovascular Disease Switching From Boosted Protease Inhibitors to Dolutegravir: A Post-hoc Analysis of the 96-week Randomised NEAT-022 Trial.
Clin Infect Dis
; 77(7): 991-1009, 2023 Oct 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37207617
7.
Screening HIV Patients at Risk for NAFLD Using MRI-PDFF and Transient Elastography: A European Multicenter Prospective Study.
Clin Gastroenterol Hepatol
; 21(3): 713-722.e3, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35436624
8.
Long-term effects on subclinical cardiovascular disease of switching from boosted protease inhibitors to dolutegravir.
J Antimicrob Chemother
; 78(9): 2361-2365, 2023 09 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37539492
9.
2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases.
Ann Rheum Dis
; 82(6): 742-753, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36328476
10.
Use of contraindicated antiretroviral drugs in people with HIV/HCV coinfections receiving HCV treatment with direct-acting antivirals-Results from the EuroSIDA study.
HIV Med
; 24(2): 224-230, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35934954
11.
Amino acids, post-translational modifications, nitric oxide, and oxidative stress in serum and urine of long COVID and ex COVID human subjects.
Amino Acids
; 55(9): 1173-1188, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37516715
12.
Diminishing Immune Responses against Variants of Concern in Dialysis Patients 4 Months after SARS-CoV-2 mRNA Vaccination.
Emerg Infect Dis
; 28(4): 743-750, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35203113
13.
Humoral immune response following prime and boost BNT162b2 vaccination in people living with HIV on antiretroviral therapy.
HIV Med
; 23(5): 558-563, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34725907
14.
Major revision version 11.0 of the European AIDS Clinical Society Guidelines 2021.
HIV Med
; 23(8): 849-858, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35338549
15.
Development of the HIV360 international core set of outcome measures for adults living with HIV: A consensus process.
HIV Med
; 23(6): 639-649, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34964226
16.
Immunogenicity of COVID-19 Vaccination in Melanoma Patients under Immune Checkpoint Blockade.
Oncology
; 100(7): 392-398, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35609553
17.
SARS-CoV-2-specific immune responses in elderly and immunosuppressed participants and patients with hematologic disease or checkpoint inhibition in solid tumors: study protocol of the prospective, observational CoCo immune study.
BMC Infect Dis
; 22(1): 403, 2022 Apr 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35468758
18.
National medical specialty guidelines of HIV indicator conditions in Europe lack adequate HIV testing recommendations: a systematic guideline review.
Euro Surveill
; 27(48)2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36695464
19.
The SARS-CoV-2 Delta-Omicron Recombinant Lineage (XD) Exhibits Immune-Escape Properties Similar to the Omicron (BA.1) Variant.
Int J Mol Sci
; 23(22)2022 Nov 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36430535
20.
Humoral and Cellular Immune Responses Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants and Human Coronaviruses After Single BNT162b2 Vaccination.
Clin Infect Dis
; 73(11): 2000-2008, 2021 12 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34134134